Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPre-MDCDRG 008-simultaneous-pancreas-and-kidney-transplant
    Ask Trek AI about this page

    Simultaneous Pancreas and Kidney Transplant: Inpatient Reimbursement Overview

    DRG 008 encompasses simultaneous pancreas and kidney transplant procedures, a high-resource inpatient surgical episode involving dual-organ transplantation and intensive posttransplant care. This Diagnosis-Related Group is important for inpatient reimbursement because it reflects the elevated resource use, length of stay, and complication risk that influence Medicare payment under the prospective payment system.

    Customize your policy alerts

    Sign up for drg 008 policy alerts

    Get alerted when payer policies referencing 008 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 008 Overview

    DRG 008 covers simultaneous pancreas and kidney transplant procedures performed during an inpatient stay, typically for patients with end-stage renal disease and insulin-dependent diabetes mellitus. This Diagnosis-Related Group captures cases with the complex operative, perioperative, and immunologic management needs associated with dual-organ transplantation. It matters for Medicare payment because resource intensity, length of stay, and posttransplant complications drive higher reimbursement relative to single-organ transplants. Accurate coding and documentation of comorbidities and complications affect payment within the Medicare inpatient prospective payment system.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Perioperative immunosuppression optimization trials: studies assessing different immunosuppressive regimens, dosing strategies, or induction protocols in simultaneous pancreas-kidney transplant recipients to minimize acute rejection and infection risk in the immediate post-transplant period. These trials focus on adult patients receiving both organs at the same operative episode, often stratified by sensitization status or comorbid diabetes complications, and examine short-term safety endpoints (rejection episodes, infectious complications) and graft function. Results are directly relevant to providers for selecting perioperative protocols and to payers because regimen choice impacts length of stay, readmission rates, and costs associated with complications.
    • Comparative effectiveness studies of surgical technique and organ preservation methods: prospective or registry-based comparative studies evaluating different operative approaches (eg, pancreas implantation sites, exocrine drainage techniques) and preservation solutions or cold ischemia management for simultaneous pancreas-kidney transplants. These studies enroll patients at the time of transplant and compare technical outcomes such as anastomotic leaks, graft thrombosis, and early graft loss, as well as OR time and transfusion needs. Findings inform surgical best practices that can reduce perioperative complications and resource utilization, which influences reimbursement, DRG resource intensity assumptions, and quality metrics.
    • Longitudinal post-discharge outcomes and health economics research: cohort studies and pragmatic trials tracking long-term patient-centered outcomes (pancreas and kidney graft survival, glycemic control, cardiovascular events), health-related quality of life, and health care utilization after hospital discharge in simultaneous pancreas-kidney recipients. These studies typically follow patients for years to assess chronic rejection, metabolic benefits of pancreas transplant, medication adherence, and downstream costs such as readmissions and outpatient specialty care. Evidence from this research helps payers and health systems understand long-term value, budget impact, and appropriate post-acute care pathways for patients assigned to this DRG.

    Related Codes

    001-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITH-MCC

    Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview

    002-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITHOUT-MCC

    Heart Transplant or Implant of Heart Assist System without MCC: Inpatient Reimbursement Overview

    003-ECMO-OR-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITH-MAJOR-O-R-PROCEDURES

    ECMO or Tracheostomy with MV >96 Hours: Inpatient Reimbursement Overview

    004-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITHOUT-MAJOR-O-R-PROCEDURES

    Tracheostomy with Mechanical Ventilation >96 Hours: Inpatient Reimbursement Overview

    005-LIVER-TRANSPLANT-WITH-MCC-OR-INTESTINAL-TRANSPLANT

    Liver Transplant with MCC or Intestinal Transplant: Inpatient Reimbursement Overview

    006-LIVER-TRANSPLANT-WITHOUT-MCC

    Liver Transplant without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    007-LUNG-TRANSPLANT

    Lung Transplant: Inpatient Reimbursement Overview

    010-PANCREAS-TRANSPLANT

    Pancreas Transplant: Inpatient Reimbursement Overview

    011-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-MCC

    Tracheostomy/Laryngectomy with MCC: Inpatient Reimbursement Overview

    012-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-CC

    Tracheostomy and Laryngectomy with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.